←
Trier Bryant169 posts
Trier Bryant avatar

Trier Bryant

@trier

Investor | Board Member | Previous @AlloyTX @JustWorkBook @Astra @Twitter @GoldmanSachs @USAirForce | @AF_Academy grad | ”good enough isn’t" | she/her

◷ Joined April 2018▧ 30 Photos and videos
Trier Bryant avatar
Trier Bryant@trier·12 Jan 2024

"What you focus on magnifies." Let's FOCUS on advancing impactful DEI initiatives for sustainable change. By MAGNIFYING the proven ROI to organizations stemming from these efforts, we can contribute to the creation of diverse, equitable, and inclusive workplaces for everyone.

Trier Bryant avatar
Trier Bryant@trier·12 Jan 2024

Despite the cyclical nature, it is crucial to continue prioritizing impactful work in this space. #GoodEnoughIsnt DEI is not merely a short sprint or a marathon with a definite endpoint; it's a continuous journey centered on *people*. Therefore, DEI isn't going anywhere.

Trier Bryant avatar
Trier Bryant@trier·5 Jan 2024

We should applaud leaders who are actively prioritizing and navigating through the distractions to maintain a forefront presence for their DEI efforts. Let's stay focused on the essential work at hand and continue driving positive change because #GoodEnoughIsnt!

Trier Bryant avatar
Trier Bryant@trier·5 Jan 2024

The noise Bill Ackman and Elon Musk have created by irresponsibly attacking DEI as “racist” and “illegal” is concerning to witness but not entirely surprising given prevailing misunderstandings around diversity, equity, and inclusion.

Trier Bryant avatar
Trier Bryant@trier·5 Jan 2024

On the other hand, companies opting to abolish DEI programming will not only lose valuable talent from underrepresented backgrounds but also the proven ROI derived from diverse teams, harming their businesses as a result.

Trier Bryant avatar
Trier Bryant@trier·5 Jan 2024

This shouldn't be misconstrued as a complete abandonment of diversity and inclusion efforts yet an approach to navigate through external distractions and concentrate on implementing impactful strategies and programs for their employees.

Trier Bryant avatar
Trier Bryant@trier·5 Jan 2024

I discussed with @paidion from @FortuneMagazine the shifting landscape where a notable percentage of companies are restructuring their approach to DEI by reducing in-house roles to strategically engage external consultants. Read more here... 👇🏾 fortune.com/2024/01/05/bill-…

Trier Bryant avatar
Trier Bryant@trier·16 Oct 2023

Excited to speak alongside these incredible women @FinancialTimes Women in Business Summit tomorrow in NYC! Register below to join us in person or virtually...👇🏾

In less than 24 hours, hear from some of the most innovative and inspiring women in business today. Join @DVF, @ValerieJarrett, @anuduggalnyc, @trier and many other remarkable figures at #FTWomen. Last chance to register: bit.ly/3RVSt73

Post attachmentPost attachmentPost attachmentPost attachment
Trier Bryant avatar
Trier Bryant@trier·27 Jul 2023

Been 1 year since I entered Biotech VC! Check out what I've been up to leading 82VS (Venture Studio @AlloyTx) pushing the boundaries of drug discovery and focusing on underserved conditions. Let’s make better medicine–together. 💊 genengnews.com/topics/drug-d…

Trier Bryant avatar
Trier Bryant@trier·11 Jan 2023

Hi @JennieNwokoye — I run a Venture Studio called 82VS @AlloyTx and this is my first #JPM2023 #JPM23. Agree with not seeing people who look like us. I have thoughts. But for now, let’s focus on you meeting people. Starting with me and my network. DM me.

I’m currently in San Francisco for the #JPM2023 #JPM23 Healthcare Conference.. and I can’t lie, it’s been very intimidating to not see people who look like me. Not a single person.

Trier Bryant avatar
Trier Bryant@trier·7 Sep 2022

I’m thrilled to bring my people-centric background at best-in-class organizations to the exciting field of life sciences and a company that is “science first, people always.”  #LetsGo

Post attachment
Trier Bryant avatar
Trier Bryant@trier·7 Sep 2022

The mission at @AlloyTx is to empower the global scientific community to make better medicines together, and 82VS specifically supports brilliant scientist entrepreneurs with the capabilities and expertise needed to start new medicines companies. alloytx.com/